OAM
BLUE

Oppenheimer Asset Management’s bluebird bio BLUE Stock Holding History

Oppenheimer Asset Management’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-460
Closed -$258K – 1168
2020
Q4 		$258K Sell
460
-42
-8% -$26.6K ﹤0.01% 1019
2020
Q3 		$351K Buy
502
+3
+0.6% +$2.34K 0.01% 900
2020
Q2 		$394K Buy
499
+15
+3% +$11.3K 0.01% 850
2020
Q1 		$288K Buy
484
+137
+39% +$134K 0.01% 878
2019
Q4 		$395K Sell
347
-47
-12% -$51.1K 0.01% 889
2019
Q3 		$468K Buy
394
+47
+14% +$71.8K 0.01% 818
2019
Q2 		$572K Buy
347
+74
+27% +$128K 0.01% 777
2019
Q1 		$557K Sell
273
-48
-15% -$84.5K 0.01% 770
2018
Q4 		$413K Buy
+321
New +$492K 0.01% 816
2017
Q4 		– Sell
-1
Closed -$1K – 1141
2017
Q3 		$1K Hold
1
– – ﹤0.01% 1638
2017
Q2 		$1K Hold
1
– – ﹤0.01% 1631
2017
Q1 		$1K Buy
+1
New +$1.02K ﹤0.01% 1656

Other funds holding BLUE

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Oppenheimer Asset Management's BLUE Position: Q1 2021 in Review

Oppenheimer Asset Management sold out of bluebird bio (BLUE) in Q1 2021, closing a stake of 460 shares — an estimated $258K sold.

Oppenheimer Asset Management first reported a position in BLUE in Q1 2017 and held it in 12 quarters. The position peaked at $572K in Q2 2019. 229 funds tracked by Wall St. Rank hold BLUE as of Q1 2021.

  • Oppenheimer Asset Management reported no remaining bluebird bio position as of Q1 2021 after selling out during the quarter.
  • Oppenheimer Asset Management sold 460 bluebird bio shares in Q1 2021, an estimated $258K.
  • Oppenheimer Asset Management first reported a position in bluebird bio in Q1 2017 and held it in 12 quarters.
  • Oppenheimer Asset Management's bluebird bio position peaked at $572K in Q2 2019.
  • 229 funds tracked by Wall St. Rank held bluebird bio as of Q1 2021.

Based on Oppenheimer Asset Management's 13F filing for Q1 2021, filed 17 May 2021.